Hereditary Sensory and Autonomic Neuropathy Type 2Symptoms, Doctors, Treatments, Advances & More
Hereditary Sensory and Autonomic Neuropathy Type 2 Overview
Learn About Hereditary Sensory and Autonomic Neuropathy Type 2
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Dysautonomia Center LLP
Horacio Kaufmann is a Neurologist practicing medicine in New York, New York. Dr. Kaufmann is rated as an Elite provider by MediFind in the treatment of Hereditary Sensory and Autonomic Neuropathy Type 2. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Familial Dysautonomia, Orthostatic Hypotension, Multiple System Atrophy, and Low Blood Pressure.
Thorsten Hornemann practices practicing medicine in Zurich, Switzerland. Mr. Hornemann is rated as an Elite expert by MediFind in the treatment of Hereditary Sensory and Autonomic Neuropathy Type 2. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Hereditary Sensory Neuropathy Type 1 (HSN1), Hereditary Sensory and Autonomic Neuropathy Type 2, Hajdu-Cheney Syndrome, Anhidrosis, and Gastric Bypass.
Ingo Kurth practices practicing medicine in Aachen, Germany. Mr. Kurth is rated as an Elite expert by MediFind in the treatment of Hereditary Sensory and Autonomic Neuropathy Type 2. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Hajdu-Cheney Syndrome, Hereditary Sensory and Autonomic Neuropathy Type 2, Hereditary Sensory Neuropathy Type 1 (HSN1), Anhidrosis, and Bone Marrow Transplant.
Summary: This clinical trial is evaluating a drug called ART0380 in participants with advanced or metastatic solid tumors. The main goals of this study are to: * Find the recommended dose of ART0380 that can be given safely to participants alone and in combination with gemcitabine or irinotecan * Learn more about the side effects of ART0380 alone and in combination with gemcitabine or irinotecan * Learn mo...
Summary: This study will test an investigational drug called AZD1390 in combination with radiation therapy for the treatment of brain tumors. This is the first time AZD1390 is being given to patients. This study will test safety, tolerability and PK (how the drug is absorbed, distributed and eliminated) of ascending doses of AZD1390 in combination with distinct regimens of radiation therapy